Literature DB >> 17281385

A Novel Remote Controlled Capsule for Human Drug Absorption studies.

Pi Xitian1, Zheng Xiaolin, Peng Chenglin, Hou Wensheng, Liu Hongying.   

Abstract

Remote Controlled Capsule (RCC) is a new method to realize non-invasive drug delivery to the selected sites of human gastro-intestinal (GI) tract. With RCC, Human Drug Absorption (HDA) studies are taken easily to obtain data on the intestinal absorption of a drug in humans. In this paper, a new RCC system has been designed based on MEMS technology to provide for the delivery of a wide range of different drug formulations, for example, solution, powder and granulate, into any region of the gut. A magnetic Marker Monitoring (MMM) system was developed to monitor the location of the capsule inside the gut. A novel method to indicating the drug release, called as Indicating System based on Abrupt Movement of Marker (ISAMM), was proposed in this study. High reliability of the RCC system has been proved by animal experiments.

Entities:  

Year:  2005        PMID: 17281385     DOI: 10.1109/IEMBS.2005.1615615

Source DB:  PubMed          Journal:  Conf Proc IEEE Eng Med Biol Soc        ISSN: 1557-170X


  3 in total

1.  Magnetically Actuated Soft Capsule With the Multimodal Drug Release Function.

Authors:  Sehyuk Yim; Kartik Goyal; Metin Sitti
Journal:  IEEE ASME Trans Mechatron       Date:  2013-01-03       Impact factor: 5.303

2.  Systemic and mucosal immune responses following oral adenoviral delivery of influenza vaccine to the human intestine by radio controlled capsule.

Authors:  Leesun Kim; C Josefina Martinez; Katie A Hodgson; George R Trager; Jennifer R Brandl; Erik P Sandefer; Walter J Doll; Dave Liebowitz; Sean N Tucker
Journal:  Sci Rep       Date:  2016-11-24       Impact factor: 4.379

Review 3.  An Overview of Robotic Capsules for Drug Delivery to the Gastrointestinal Tract.

Authors:  Pablo Cortegoso Valdivia; Alexander R Robertson; Nanne K H De Boer; Wojciech Marlicz; Anastasios Koulaouzidis
Journal:  J Clin Med       Date:  2021-12-10       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.